Substance misuse at presentation to an early psychosis program.
about
Q24197685Cannabis and psychosis/schizophrenia: human studiesSubstance use in clinical high risk for psychosis: a review of the literatureThe effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Striatal dopamine release in schizophrenia comorbid with substance dependence.Alcohol and Relatively Pure Cannabis Use, but Not Schizotypy, are Associated with Cognitive Attenuations.Pathways from cannabis to psychosis: a review of the evidence.Quality of life and recreational cannabis use.Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosisScreening for substance use disorders in first-episode psychosis: implications for readmission.The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.Diagnostic change 10 years after a first episode of psychosisAssociation between age at onset of psychosis and age at onset of cannabis use in non-affective psychosisWeight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcomeEARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA.A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches.Status of first-episode psychosis patients presenting for routine care in a defined catchment area.Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments OfferedSex difference in age of onset of schizophrenia: findings from a community-based study in India.Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosisMarijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.Substance misuse and early psychosis.Substance use and abuse in first-episode psychosis: prevalence before and after early interventionComorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.Prevalence of Substance Use in People With First-Episode Psychosis.The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.Substance abuse and smoking among a Canadian cohort of first episode psychosis patients.Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia.Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?First-episode psychosis in rural, coastal and remote Australian communities.Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications.The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
P2860
Q24197685-D3C0335B-C01E-4301-A565-3E99A19A2203Q24628837-72B9CEC0-EF0A-4BAE-91FA-A6084D414691Q26859349-0927388D-12D8-4F5C-AEAD-366F85575020Q31149257-7417E98D-E166-4006-85CF-4FB2AB376834Q33976751-339CC333-3490-47E5-B8D1-0011711A07C0Q34028727-29AD5B3B-2CF2-4F7A-A9AC-35BF8CC27195Q34259699-C713D91F-D7AC-4D5D-83EC-441F71FB2C7DQ34378233-A3503E8B-EBB2-4951-8CAD-E8D0517D8E4FQ34547776-5DABDE8F-6F4B-4148-A605-534B3D7D030DQ34612418-DC1AFE50-BDF6-4A63-9DB3-29F178C5FB6CQ34644737-C296903D-CB11-4389-B273-ACED29AD95EDQ35323897-BEFB14CB-DEB3-4F27-BDC9-39D60553FB0EQ36059843-CAFAECD0-A139-4C39-9548-CB7A8DE4F9F1Q36129243-1DDE8B9D-A717-44DE-AE92-CA19321E452BQ36154276-AE40D0A2-1ABC-4AD1-8731-40CE92CB0F20Q36178681-EC901734-15EF-4883-87A1-72ED9FD13CD6Q36281966-96679B00-D351-4F71-9743-F5F447984984Q36318838-44050957-134E-468B-BAB5-6DB0096B2759Q36364218-B429C410-E76C-4646-B71D-D1138D17EF50Q36402481-D4F634EE-AC3F-4D86-AB39-8A8979A34029Q36914975-0CCF33C9-5D4A-4527-89BB-3BA10214D0E8Q36919958-D61DDA7C-5165-4D57-BADA-A7982B927FFFQ37036013-1CACAB72-41F4-49AC-A57A-A17127DAE877Q37057539-5FD40C92-74F6-47D1-9B75-2A14E4B1A30DQ37259866-592C2A78-5D1D-4AB3-8678-7ABB5ED94562Q37304782-725B93BB-AD1D-4DF4-A81A-E8C11F69A221Q37419167-BBABD172-86B5-4897-BBAC-19A68A677C0AQ37427095-4EEC4AB6-462C-4FDA-95C9-79603DF2CEC2Q38124448-1FD1E3DF-A2C1-41B6-95DE-69C2AD4D9187Q38765609-F5E41ED2-9916-4DDE-AD60-882E48CCDDD1Q38960232-F482F8FC-6AF6-41B9-BCFB-A27E4F6A3B1CQ39789560-735ACE8C-C976-4CE4-B2B3-CBEB332B5A27Q40118413-45E67A1D-D997-4EAF-8702-BB876E4461EFQ40175951-224E32E0-71BD-4ED3-A085-9D816F272441Q41171926-8FA791E7-B895-4053-A7D6-DA04CF545E42Q44459467-C9BFBB94-0043-469E-872A-71FC03EF854EQ44538840-CF1818BC-5880-471E-8388-3B799BD7DB6DQ46066974-7854AC9F-31F0-43F6-83F5-FA9FBADB104EQ46942618-A1912404-8396-4B94-9C72-1ECB1E8454D3Q48246767-5A34FE03-851D-48AD-92B8-F3E82C46B2D7
P2860
Substance misuse at presentation to an early psychosis program.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Substance misuse at presentation to an early psychosis program.
@en
Substance misuse at presentation to an early psychosis program.
@nl
type
label
Substance misuse at presentation to an early psychosis program.
@en
Substance misuse at presentation to an early psychosis program.
@nl
prefLabel
Substance misuse at presentation to an early psychosis program.
@en
Substance misuse at presentation to an early psychosis program.
@nl
P1476
Substance misuse at presentation to an early psychosis program.
@en
P2093
Donald Addington
Sarah Van Mastrigt
P356
10.1007/S00127-004-0713-0
P577
2004-01-01T00:00:00Z